<bill session="118" type="s" number="1139" updated="2025-11-18T18:43:26Z">
  <state datetime="2023-03-30">REFERRED</state>
  <status>
    <introduced datetime="2023-03-30"/>
  </status>
  <introduced datetime="2023-03-30"/>
  <titles>
    <title type="display">Lower Drug Costs for Families Act</title>
    <title type="short" as="introduced">Lower Drug Costs for Families Act</title>
    <title type="official" as="introduced">A bill to amend title XVIII of the Social Security Act to apply prescription drug inflation rebates to drugs furnished in the commercial market and to change the base year for rebate calculations.</title>
  </titles>
  <sponsor bioguide_id="C001113"/>
  <cosponsors>
    <cosponsor bioguide_id="B001230" joined="2023-03-30"/>
    <cosponsor bioguide_id="B001277" joined="2023-03-30"/>
    <cosponsor bioguide_id="B000944" joined="2023-03-30"/>
    <cosponsor bioguide_id="G000555" joined="2023-04-26"/>
    <cosponsor bioguide_id="K000367" joined="2023-03-30"/>
    <cosponsor bioguide_id="R000122" joined="2023-03-30"/>
    <cosponsor bioguide_id="S001203" joined="2023-03-30"/>
    <cosponsor bioguide_id="S000770" joined="2023-03-30"/>
    <cosponsor bioguide_id="W000800" joined="2023-03-30"/>
  </cosponsors>
  <actions>
    <action datetime="2023-03-30">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-03-30" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills>
    <bill session="118" type="h" number="4115" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Government information and archives"/>
    <term name="Health care costs and insurance"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2023-11-13T20:27:47Z" status="Introduced in Senate">Lower Drug Costs for Families Act

This bill applies certain Medicare prescription drug rebate requirements to prescription drugs that are available under private health insurance.

Current law requires drug manufacturers to issue rebates to the Centers for Medicare &amp; Medicaid Services for brand-name drugs without generic equivalents under Medicare that (1) cost $100 or more per year per individual, and (2) for which prices increase faster than inflation. Manufacturers that fail to comply are subject to civil penalties.

The bill applies these requirements to prescription drugs that are available in the commercial market under private health insurance. It also indexes rebate calculations to drug prices in 2016 (as opposed to 2021).</summary>
</bill>
